Phone: 614/488-2118
Fax: 614/488-2647
1335 Dublin Rd., Suite 124A
Columbus, OH 43215
Member Sign in
HOME
MEMBERS
CANCER RESOURCES
ABOUT
EVENTS
EMPLOYMENT
CONTACT
Protocol Database
User Profile
Index of Forms
Ohio Partners for Cancer Control
Consortium Members
Treatment Sites & Physicians
Community Based Research Nurses
NCORP Videos
Our Team
Donate
HOME
MEMBERS
Protocol Database
User Profile
Index of Forms
CANCER RESOURCES
Ohio Partners for Cancer Control
ABOUT
Consortium Members
Treatment Sites & Physicians
Community Based Research Nurses
NCORP Videos
EVENTS
EMPLOYMENT
CONTACT
Our Team
Donate
Enter your search term
Protocol Categories
View All Protocols
PROTOCOL CREDENTIALS
Brain
Breast
CA Control
CCDR
Gastrointestinal
Genitourinary
GYN
Head and Neck
Hematology
Lung
Lymphoma
Melanoma / Skin-Other
Multiple Disease Sites
Observational
RT
Sarcoma
Unknown Primary
DCP
Brain
NCCTG N0577
Phase III Intergroup Study of Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherpy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma
NCI COVID-19
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NRG BN007
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
SWOG S1827
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Wake Forest WF 1801
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy